VR Logo

Concord Drugs: Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2022.

Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2022 inter alia to consider and approve Approval of unaudited financial results for the quarter ended 30.06.2022.

Click here to view PDF